The fundamental role of CD4+T cells in anti-tumor process was further enhanced by the finding that immunogenic tumor mutations in the “mutanomes” of three separate preclinical mouse tumor models induced a CD4+T cell response but not a CD8+T cells response as had been expected8. The gene discussed is CD8A; the disease is neoplasm.